Standout Papers

Effective treatment of severe COVID-19 patients with tocilizumab 2020 2026 2022 20241.8k
  1. Effective treatment of severe COVID-19 patients with tocilizumab (2020)
    Xiaoling Xu, Mingfeng Han et al. Proceedings of the National Academy of Sciences

Immediate Impact

7 from Science/Nature 63 standout
Sub-graph 1 of 20

Citing Papers

Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
2023 Standout
4 intermediate papers

Works of Dongsheng Wang being referenced

Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Activation of IL ‐27 signalling promotes development of postinfluenza pneumococcal pneumonia
2013

Author Peers

Author Last Decade Papers Cites
Dongsheng Wang 193 1510 358 873 35 2.3k
Aijun Pan 166 1603 389 896 29 2.1k
Yun Yang 168 1935 508 891 26 2.6k
Ying Liu 271 1394 356 754 31 2.0k
Bili Wang 200 1446 406 831 21 2.3k
Yueping Liu 258 1718 475 888 30 2.4k
Xiewan Chen 351 1362 407 751 24 2.0k
Tiantian Li 186 1521 320 867 15 2.0k
Bo Diao 345 1879 487 992 41 2.7k
Zhao Wu 288 991 271 623 26 1.8k
Zhengyin Liu 171 1278 219 557 45 1.8k

All Works

Loading papers...

Rankless by CCL
2026